Exchange: NASDAQ·Updated 04:29 PM EDT
NERV logo

NERV Minerva Neurosciences Inc

$4.35
$0.26
(5.54%)
Today
Closed $4.43
$0.08
(1.81%)
After Hours
Reported EarningsAug 7
Mkt Cap$223.94M
Vol78,435.00

About NERV

Minerva Neurosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of a portfolio of product candidates to treat central nervous system diseases. It develops Roluperidone for the treatment of negative symptoms in patients with schizophrenia and MIN-301 for the treatment of Parkinson’s disease. The company was founded by Rogerio Vivaldi Coelho and Goeffrey Robin Race on April 23, 2007 and is headquartered in Burlington, MA.
52

Neutral Sentiment

How do you feel about NERV?

Advertisement|Remove ads.